Evaluating change in mobility in people with multiple sclerosis: Relative responsiveness of four clinical measures

Multiple Sclerosis Journal

Volumn 19, Issue 12, 2013, Pages 1632-1639

  Freeman, Jennifer ^a   Walters, Richard ^a   Ingram, Wendy ^b   Slade, Anita ^a   Hobart, Jeremy ^b   Zajicek, John ^b  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

measures of mobility; mobility; Multiple sclerosis; outcomes; responsiveness; study design

Indexed keywords

ADULT; AGED; ALGORITHM; ANALYSIS OF VARIANCE; DAILY LIFE ACTIVITY; DISABILITY; DISEASE COURSE; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; TREATMENT OUTCOME; UNITED KINGDOM; WALKING; WALKING DIFFICULTY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ALGORITHMS; ANALYSIS OF VARIANCE; DISABILITY EVALUATION; DISEASE PROGRESSION; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; MOBILITY LIMITATION; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; TREATMENT OUTCOME; WALKING;

EID: 84885761647     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513482373     Document Type: Article

References (34)

1. Sutliff MH. Contribution of impaired mobility to patient burden in multiple sclerosis. Curr Med Res Op. 2010 ; 26: 109
2. Jones SL, Warren S, Turpin KVL, et al. The burden of multiple sclerosis: A community health survey. Health QoL Out. 2008 ; 6: 1
3. Heesen CBJ, Reich C, Kasper J, et al. Patient perception of bodily functions in multiple sclerosis: Gait and visual function are the most valuable. Mult Scler. 2008 ; 14: 998-991
4. Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler J. 2012 ; 18: 914-924
5. Freeman JA, Hobart JC, Playford ED, et al. Evaluating neurorehabilitation: Lessons from routine data collection. J Neurol Neurosurg Psychiatry. 2005 ; 76: 723-728
6. Zwiebel H. Health and quality of life in patients with relapsing multiple sclerosis: Making the intangible tangible. J Neurolog Sci. 2009 ; 287: S11-16
7. Salter AR, Cutter GR, Tyry T, et al. Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Op. 2010 ; 26: 493-500
8. Kesselring J. Disease progression in multiple sclerosis: I. Impaired mobility and its impact on limitations of activities and social participation. Eur Neurolog Rev. 2010: 56-60
9. Hobart JC, Cano SJ, Zajicek JP, et al. Rating scales as outcome measures for clinical trials in neurology: Problems, solutions and recommendations. Lancet Neurol. 2007 ; 6: 1094-1105
10. Hobart JC, Riazi A, Lamping DL, et al. Measuring the impact of MS on walking ability; The 12-item MS Walking Scale (MSWS-12). Neurology. 2003 ; 60: 31-36
11. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008 ; 14: 383-390
12. Cattaneo D, Jonsdottir J, Repetti S. Reliability of four scales on balance disorders in persons with multiple sclerosis. Disabil Rehab. 2007 ; 29: 1920-1925
13. Tyson S, Connell L. The psychometric properties and clinical utility of measures of walking and mobility in neurological conditions: A systematic review. Clin Rehab. 2009 ; 23: 1018-1033
14. Gijbels D, Dalgas U, Romberg A, et al. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set. Mult Scler J. 2012 ; 18: 364-371
15. Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008 ; 61: 102-109
16. Management of multiple sclerosis in primary and secondary care. London: National Institute of Clinical Excellence ; 2003:
17. Zajicek J, Ingram W, Vickery J, et al. Patient-orientated longitudinal study of multiple sclerosis in South West England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort. BMC Neurology. 2010 ; 10: 88
18. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria.". Ann Neurol. 2005 ; 58: 840-846
19. Gijbels D, Alders G, Van Hoof E, et al. Predicting habitual walking performance in multiple sclerosis: Relevance of capacity and self-report measures. Mult Scler. 2010 ; 16: 618-626
20. Gijbels D, Eijnde BO, Feys P. Comparison of the 2- and 6-minute walk test in multiple sclerosis. Mult Scler J. 2011 ; 17: 1269-1272
21. American Thoracic Society Statement; guidelines for the six-minute walk test. Am J Resp Critical Care Med. 2002 ; 166: 111-117
22. Graham JE, Ostir GV, Fisher SR, et al. Assessing walking speed in clinical research: A systematic review. J Eval Clin Pract. 2008 ; 14: 552-562
23. Morris ME, Cantwell C, Vowels L, et al. Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002 ; 72: 361-365
24. Hobart J, Cano S, Ingram W, et al. A new path forward for the MS walking scale: MSWS012v2. Mult Scler J. 2012 ; 18: 334-335
25. McGuigan C, Hutchinson M. Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12). Neurology. 2004 ; 62: 2103-2105
26. De Groot V, Beckerman H, Uitdehaag BM, et al. The usefulness of evaluative outcome measures in patients with multiple sclerosis. Brain. 2006 ; 129: 2648-2659
27. Cohen J Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates ; 1988:
28. Wyrwich KW, Nienaber NA, Tierney WM, et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999 ; 37: 469-478
29. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008 ; 9: 105-121
30. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
31. Dalgas U, Severinsen K, Overgaard K. Relations between 6 minute walking distance and 10 meter walking speed in patients with multiple sclerosis and stroke. Arch Phys Med Rehab. 2012 ; 93: 1167-1172
32. Debouverie M, Pittion-Vouyovitch S, Louis S, et al. Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol. 2008 ; 15: 916-921
33. Vazirinejad R, Lilley J, Ward C. A health profile of adults with multiple sclerosis living in the community. Mult Scler. 2008 ; 14: 1099-1105
34. Paltamaa J, Sarasoja T, Leskinen E, et al. Measures of physical functioning predict self-reported performance in self-care, mobility, and domestic life in ambulatory persons with multiple sclerosis. Arch Phys Med Rehab. 2007 ; 88: 1649-1657